Thrombocytopenia in Staphylococcus aureus bacteremia: Risk factors and prognostic importance

Mayo Clinic Proceedings

Volumn 86, Issue 5, 2011, Pages 389-396

  Gafter Gvili, Anat ^a,b   Mansur, Nariman ^a,b   Bivas, Assaf ^a,b   Zemer Wassercug, Noa ^a,b   Bishara, Jihad ^a,b   Leibovici, Leonard ^a,b   Paul, Mical ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLOOD CULTURE; COHORT ANALYSIS; COMMUNICABLE DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOCARDITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SEPTIC SHOCK; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; THROMBOCYTOPENIA;

EID: 79955648474     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/mcp.2010.0705     Document Type: Article

References (37)

1. Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169(5):463-473.
2. de Haas CJ, Weeterings C, Vughs MM, et al. Staphylococcal superantigen-like 5 activates platelets and supports platelet adhesion under flow conditions, which involves glycoprotein Ibalpha and alpha IIb beta 3. J Thromb Haemost. 2009;7(11):1867-1874.
3. Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol. 2006;4(6):445-457. (Pubitemid 43771864)
4. Spika JS, Peterson PK, Wilkinson BJ, et al. Role of peptidoglycan from Staphylococcus aureus in leukopenia, thrombocytopenia, and complement activation associated with bacteremia. J Infect Dis. 1982;146(2):227-234. (Pubitemid 12009788)
5. Kerrigan SW, Clarke N, Loughman A, et al. Molecular basis for Staphylococcus aureus-mediated platelet aggregate formation under arterial shear in vitro. Arterioscler Thromb Vasc Biol. 2008;28(2):335-340. (Pubitemid 351161208)
6. Buyukasyk NS, Ileri M, Alper A, et al. Increased blood coagulation and platelet activation in patients with infective endocarditis and embolic events. Clin Cardiol. 2004;27(3):154-158. (Pubitemid 38269658)
7. Niemann S, Spehr N, Van Aken H, et al. Soluble fibrin is the main mediator of Staphylococcus aureus adhesion to platelets. Circulation. 2004;110(2):193-200. (Pubitemid 38924588)
8. Leibovici L, Gransden WR, Eykyn SJ, et al. Clinical index to predict bacteraemia caused by staphylococci. J Intern Med. 1993;234(1):83-89. (Pubitemid 23240563)
9. Paul M, Kariv G, Goldberg E, et al. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2010;65(12):2658-2665.
10. Paul M, Zemer-Wassercug N, Talker O, et al. Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia [published online ahead of print November 13, 2010]? Clin Microbiol Infec. doi: 10.1111/j.1469-0691.2010.03425.x.
11. Friedman ND, Kaye KS, Stout JE, et al. Health care - associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137(10):791-797. (Pubitemid 35334450)
12. Levi M, Toh CH, Thachil J, et al; British Committee for Standards in Haematology. Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol. 2009;145(1):24-33.
13. van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res. 2007;16(3):219-242. (Pubitemid 47018660)
14. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet. 2005;365(9453):63-78.
15. Levy MM, Fink MP, Marshall JC, et al; International Sepsis Definitions Conference. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250-1256.
16. Ferreira FL, Bota DP, Bross A, et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286(14):1754-1758. (Pubitemid 33010262)
17. Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23(10):1638-1652.
18. Francois B, Trimoreau F, Vignon P, et al. Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med. 1997;103(2):114-120. (Pubitemid 27352115)
19. Levi M. Platelets in sepsis. Hematology. 2005;10(suppl 1):129-131. (Pubitemid 41825706)
20. Stephan F, Thioliere B, Verdy E, et al. Role of hemophagocytic histiocytosis in the etiology of thrombocytopenia in patients with sepsis syndrome or septic shock. Clin Infect Dis. 1997;25(5):1159-1164. (Pubitemid 27513204)
21. Big C, Malani PN. Staphylococcus aureus bloodstream infections in older adults: clinical outcomes and risk factors for in-hospital mortality. J Am Geriatr Soc. 2010;58(2):300-305.
22. Fowler VG Jr, Olsen MK, Corey GR, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med. 2003;163(17):2066-2072. (Pubitemid 37151249)
23. Gastmeier P, Sohr D, Geffers C, et al. Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German Nosocomial Infection Surveillance System (KISS). Infection. 2005;33(2):50-55. (Pubitemid 40590991)
24. Malani PN, Rana MM, Banerjee M, et al. Staphylococcus aureus bloodstream infections: the association between age and mortality and functional status. J Am Geriatr Soc. 2008;56(8):1485-1489.
25. Nickerson EK, Wuthiekanun V, Wongsuvan G, et al. Factors predicting and reducing mortality in patients with invasive Staphylococcus aureus disease in a developing country. PLoS ONE. 2009;4(8):e6512.
26. Sy RW, Chawantanpitat C, Richmond DR, et al. Thrombocytopenia and mortality in infective endocarditis. J Am Coll Cardiol. 2008;51(18):1824-1825. (Pubitemid 351608492)
27. Wang JL, Chen SY, Wang JT, et al. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis. 2008;46(6):799-806.
28. Willcox PA, Rayner BL, Whitela w DA. Community-acquired Staphylococcus aureus bacteraemia in patients who do not abuse intravenous drugs. QJM. 1998;91(1):41-47. (Pubitemid 28041005)
29. Arvand M, Bhakdi S, Dahlback B, et al. Staphylococcus aureus alphatoxin attack on human platelets promotes assembly of the prothrombinase complex. J Biol Chem. 1990;265(24):14377-14381.
30. Manohar M, Maheswaran SK, Frommes SP, et al. Platelet damaging factor, a fifth activity of staphylococcal alpha-toxin. J Bacteriol. 1967;94(1):224-231.
31. Moreillon P, Entenza JM, Francioli P, et al. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun. 1995;63(12):4738-4743.
32. Bayer AS, Sullam PM, Ramos M, et al. Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains. Infect Immun. 1995;63(9):3634-3641.
33. Sullam PM, Bayer AS, Foss WM, et al. Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis. Infect Immun. 1996;64(12):4915-4921. (Pubitemid 26403941)
34. Kupferwasser LI, Yeaman MR, Shapiro SM, et al. Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects. Circulation. 1999;99(21):2791-2797. (Pubitemid 29250026)
35. Sullam PM, Frank U, Yeaman MR, et al. Effect of thrombocytopenia on the early course of streptococcal endocarditis. J Infect Dis. 1993;168(4):910-914. (Pubitemid 23282564)
36. Vandijck DM, Blot SI, De Waele JJ, et al. Thrombocytopenia and outcome in critically ill patients with bloodstream infection. Heart Lung. 2010;39(1):21-26.
37. Chan KL, Dumesnil JG, Cujec B, et al. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol. 2003;42(5):775-780. (Pubitemid 37059731)